41 – 50 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma
(
- Contribution to journal › Article
-
Mark
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Nedärvd alfa-1-antitrypsinbrist kan orsaka KOL. Substitutionsbehandling tycks ge färre infektioner och förlingd överlevnad.
(
- Contribution to journal › Scientific review
-
Mark
Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression
2007) In Neurobiology of Aging(
- Contribution to journal › Article
-
Mark
New insights into the understanding of gastrointestinal dysmotility
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
(
- Contribution to journal › Article
-
Mark
alpha1-Antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release.
(
- Contribution to journal › Article
-
Mark
C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways.
(
- Contribution to journal › Article
-
Mark
Do native and polymeric alpha1-antitrypsin activate human neutrophils in vitro?
(
- Contribution to journal › Article